ATTGENO AB
556692-7751ActiveDeveloping targeted nitric oxide delivery drugs for critical care applications.
Oversikt
- 1–4
- Ansatte
- ≤1t SEK
- Omsetning
- 2005
- Grunnlagt
Beskrivelse
Attgeno is a Swedish biotechnology company focused on saving patient lives through advanced drug delivery systems. Their core mission revolves around the targeted delivery of nitric oxide (NO), a vital molecule in various physiological processes. The company is pioneering the third generation of NO...
Tagger
Nøkkelord
Bedriftsinformasjon
- Bransje
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE556692775101
Beslutningstakere
Ingen beslutningstakere funnet ennå
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrCereno Scientific AB
10–19 ansattePioneering disease-modifying treatments for rare cardiovascular and pulmonary diseases.
LobSor Pharmaceuticals Aktiebolag
1–4 ansatteDeveloping innovative therapy systems for advanced Parkinson's disease treatment.
MucoLife Therapeutics AB
1–4 ansatteDeveloping novel mucus modulators to treat COPD and Cystic Fibrosis.
Sangair AB
5–9 ansatteDeveloping revolutionary blood treatment technology to combat severe sepsis infections.
Omnio Healer AB
0 ansatteDeveloping regenerative plasminogen therapy to heal chronic wounds effectively.
Utforsk mer
Spørsmål om ATTGENO AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo